Endovascular repair of traumatic rupture of the aortic isthmus: Midterm results

Abstract

This study demonstrates that the endovascular treatment of blunt thoracic aortic traumatisms is a safe and effective therapeutic method without increased midterm morbidity and mortality rates.

Open versus endovascular repair of acute aortic transections—a non-randomized single-center analysis

“…This initial survival benefit is sustained during midterm follow-up although it did not reach statistical significance (log rank test, p=0.077) due to the relatively small number of patients in both groups. Mortality rates after TEVAR for TAT vary between 0% and 14.2% and are thus in line with our reported results [7,[15][16][17]. Although retrospective series have shown a reduced mortality of TEVAR versus OR, most singlecenter studies, such as ours, failed to show a statistical significance due to the relatively small patient cohorts [6,[18][19][20].…”

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

“…Although endovascular stent grafting has not been prospectively studied for this clinical scenario, US Food and Drug Administration-approved devices are being used "off label," with considerable success reported based on retrospective studies. In a collected series of 284 patients reported in the literature, Lettinga-van de Poll and colleagues reported the procedure-related mortality was 1.5%, 6.7% had endoleaks, and 14.4% had procedure-related complications (358,(365)(366)(367)(368)(369)(370). In a multicenter study of 30 patients with 100% implantation success, 6% to 7% of patients died, 1 had a stroke (3.3%), and 1 had partial stent collapse (3.3%) (370).…”

Tevar

“…In addition, all patients showed complete reconstruction of the aortic wall without any residual pseudoaneurysm and shrinking of the aorta over the stent-graft without any signs of paraplegia during a mean follow-up of 46 months [62]. …”